CC BY 4.0 · ACI open 2020; 04(02): e136-e148
DOI: 10.1055/s-0040-1718542
Original Article

Discovery of Comorbid Psychiatric Conditions among Youth Detainees in Juvenile Justice System using Clinical Data

Humayera Islam
1   Department of Health Management and Informatics, University of Missouri, Columbia, Missouri, United States
2   Institute of Statistical Research and Training, University of Dhaka, Dhaka, Bangladesh
3   Center for Biomedical Informatics, School of Medicine, University of Missouri, Columbia, Missouri, United States
,
Abu S. M. Mosa
1   Department of Health Management and Informatics, University of Missouri, Columbia, Missouri, United States
3   Center for Biomedical Informatics, School of Medicine, University of Missouri, Columbia, Missouri, United States
4   Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, United States
5   Department of Electrical and Computer Science, University of Missouri, Columbia, Missouri, United States
,
Hirsch K. Srivastava
6   Department of Psychiatry, School of Medicine, University of Missouri, Columbia, Missouri, United States
,
Vasanthi Mandhadi
3   Center for Biomedical Informatics, School of Medicine, University of Missouri, Columbia, Missouri, United States
,
Dhinakaran Rajendran
1   Department of Health Management and Informatics, University of Missouri, Columbia, Missouri, United States
,
Laine M. Young-Walker
6   Department of Psychiatry, School of Medicine, University of Missouri, Columbia, Missouri, United States
› Author Affiliations
Funding None.

Abstract

Objective The main aim was to analyze the prevalence and patterns of comorbidity in 11 identified broad categories of psychiatric conditions and 48 specific psychiatric conditions among 613 youth from the Missouri Division of Youth Services (DYS) residential sites using advanced data mining techniques on clinical assessment data.

Methods This study was based on youth detainee population at DYS residential placements receiving psychiatric care through the telemedicine network established between DYS and University of Missouri Department of Psychiatry. Association Rule Mining (ARM) algorithm was used to determine the associations and the co-occurrence pattern among the comorbid psychiatric conditions.

Results About 88% of the DYS youth are diagnosed with two or more psychiatric disorders. From the ARM analysis, the most commonly co-occurred disorders are obtained as substance-related or -addicted disorders (SUD) and disruptive, impulse-control, and conduct disorders (CD) (n [%] = 258 [42.1%], followed by SUD, CD, and depressive disorder (DD) (145 [23.7%]), SUD, CD, and neurodevelopmental disorder (NDD) (133 [21.7%]), and DD, CD and NDD (120 [19.6%]).

Discussion The study found high prevalence of comorbidity among the youth patients of the Missouri DYS facilities receiving care through the University of Missouri telemedicine network. The ideal scenario for assessment of any of these disorders in a patient should include substantial consideration in delineating the symptoms and history before eliminating any of them.

Conclusion The comorbid patterns obtained can help in determining treatment regimens for DYS youth that can be effective in reducing recidivism and delinquency.

Protection of Human and Animal Subjects

The study was approved by University of XXX Institutional Review Board.




Publication History

Received: 12 February 2020

Accepted: 27 August 2020

Article published online:
17 November 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Harp C, Hockenberry S, Sladky A. Juvenile Residential Facility Census, 2016: Selected Findings, National Report Series Bulletin. 2018 . Available at: http://ncjj.org/Publication/Juvenile-Residential-Facility-Census-2016-Selected-Findings.aspx. Accessed January 16, 2020
  • 2 Fazel S, Doll H, Långström N. Mental disorders among adolescents in juvenile detention and correctional facilities: a systematic review and metaregression analysis of 25 surveys. J Am Acad Child Adolesc Psychiatry 2008; 47 (09) 1010-1019
  • 3 Snyder HN. Juvenile Arrests, Office of Juvenile Justice and Delinquency Prevention, U.S. Department of Justice. 2002 . Available at: https://www.ncjrs.gov/pdffiles1/ojjdp/223612.pdf. Accessed October 18, 2019
  • 4 Skowyra K, Cocozza JJ. A blueprint for change: improving the system response to youth with mental health needs involved with the juvenile justice system. 2006 . Available at: https://www.ncmhjj.com/wp-content/uploads/2013/07/2007_Blueprint-for-Change-Full-Report.pdf. Accessed October 18, 2019
  • 5 Burke JD, Mulvey EP, Schubert CA. Prevalence of mental health problems and service use among first-time juvenile offenders. J Child Fam Stud 2015; 24 (12) 3774-3781
  • 6 Grisso T. Adolescent offenders with mental disorders. Future Child 2008; 18 (02) 143-164
  • 7 Washburn JJ, Teplin LA, Voss LS, Simon CD, Abram KM, McClelland GM. Psychiatric disorders among detained youths: a comparison of youths processed in juvenile court and adult criminal court. Psychiatr Serv 2008; 59 (09) 965-973
  • 8 Underwood LA, Washington A. Mental illness and juvenile offenders. Int J Environ Res Public Health 2016; 13 (02) 228
  • 9 Gilbert AL, Grande TL, Hallman J, Underwood LA. Screening incarcerated juveniles using the MAYSI-2. J Correct Health Care 2015; 21 (01) 35-44
  • 10 Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees. Implications for public policy. Am Psychol 1991; 46 (10) 1036-1045
  • 11 Abram KM, Teplin LA, McClelland GM. Comorbidity of severe psychiatric disorders and substance use disorders among women in jail. Am J Psychiatry 2003; 160 (05) 1007-1010
  • 12 Teplin LA, Abram KM, McClelland GM, Dulcan MK, Mericle AA. Psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry 2002; 59 (12) 1133-1143
  • 13 Barkley R. Attention-Deficit/Hyperactivity Disorder. New York City, NY: Guilford Publications; 2006
  • 14 Frick PJ. Conduct Disorders and Severe Antisocial Behavior. Berlin, Germany: Springer Science & Business Media; 1998
  • 15 Costello EJ, Angold A, Burns BJ. et al. The great smoky mountains study of youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry 1996; 53 (12) 1129-1136
  • 16 Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998; 18 (07) 765-794
  • 17 Abram KM, Teplin LA, McClelland GM, Dulcan MK. Comorbid psychiatric disorders in youth in juvenile detention. Arch Gen Psychiatry 2003; 60 (11) 1097-110
  • 18 Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006; 256 (01) (Suppl. 01) i26-i31
  • 19 Colins O, Vermeiren R, Vreugdenhil C, van den Brink W, Doreleijers T, Broekaert E. Psychiatric disorders in detained male adolescents: a systematic literature review. Can J Psychiatry 2010; 55 (04) 255-263
  • 20 Teplin LA, Abram KM, Washburn JJ, Welty LJ, Hershfield JA, Dulcan MK. The Northwestern juvenile project: overview. Available at: https://ojjdp.ojp.gov/sites/g/files/xyckuh176/files/pubs/234522.pdf. Accessed February, 2013
  • 21 Chen T-J, Chou L-F, Hwang S-J. Application of a data-mining technique to analyze coprescription patterns for antacids in Taiwan. Clin Ther 2003; 25 (09) 2453-2463
  • 22 Tai Y-M, Chiu H-W. Comorbidity study of ADHD: applying association rule mining (ARM) to National Health Insurance Database of Taiwan. Int J Med Inform 2009; 78 (12) e75-e83
  • 23 Held F, Le Couteur DG, Blyth FM. et al. Polypharmacy in older adults: association rule and frequent-set analysis to evaluate concomitant medication use. Pharmacol Res 2017; 116: 39-44
  • 24 Boytcheva S, Angelova G, Angelov Z, Tcharaktchiev D. Mining comorbidity patterns using retrospective analysis of big collection of outpatient records. Health Inf Sci Syst 2017; 5 (01) 3
  • 25 Kost R, Littenberg B, Chen ES. Exploring generalized association rule mining for disease co-occurrences. AMIA. Annu Symp proceedings AMIA Symp. 2012;2012(2012):1284–1293. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23304407. Accessed November 13, 2019
  • 26 Shen C-C, Hu L-Y, Hu Y-H. Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database. BMC Med Inform Decis Mak 2017; 17 (01) 8
  • 27 Kim L, Myoung S. Comorbidity study of attention-deficit hyperactivity disorder (ADHD) in children: applying association rule mining (ARM) to Korean National Health Insurance Data. Iran J Public Health 2018; 47 (04) 481-488
  • 28 Wang C-H, Lee T-Y, Hui K-C, Chung M-H. Mental disorders and medical comorbidities: Association rule mining approach. Perspect Psychiatr Care 2019; 55 (03) 517-526
  • 29 American Psychological Association (APA). Diagnostic and statistical manual of mental disorders. American Psychiatric Publishing, Inc; 2013. DOI: 10.1176/appi.books.9780890425596.dsm04
  • 30 Agrawal R, Imieliński T, Swami A. Mining association rules between sets of items in large databases. SIGMOD Rec 1993; 22 (02) 207-216
  • 31 R Core Team. R: a language and environment for statistical computing. Available at:https://www.r-project.org/. Accessed 2018
  • 32 Hahsler M, Chelluboina S, Buchta C. The arules R-package Ecosystem: analyzing interesting patterns from large transaction datasets. J Mach Learn Res 2011; 12: 1977 :1981. Available at: http://www.jmlr.org/papers/volume12/hahsler11a/hahsler11a.pdf
  • 33 Borgelt C, Kruse R. Induction of Association Rules: Apriori Implementation. Hiedelberg: Compstat, Physica; 2002: 395-400 . Available at: https://link.springer.com/chapter/10.1007/978-3-642-57489-4_59. Accessed June 26, 2019
  • 34 Hahsler M. A probabilistic comparison of commonly used interest measures for association rules. Available at: https://michael.hahsler.net/research/association_rules/measures.html. Accessed May 28, 2020
  • 35 Shaffer D, Fisher P, Dulcan MK. et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 1996; 35 (07) 865-877
  • 36 Bukstein OG, Horner MS. Management of the adolescent with substance use disorders and comorbid psychopathology. Child Adolesc Psychiatr Clin N Am 2010; 19 (03) 609-623
  • 37 van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W. et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012; 122 (1-2): 11-19
  • 38 Rogers KM, Zima B, Powell E, Pumariega AJ. Who is referred to mental health services in the juvenile justice system?. J Child Fam Stud 2001; 10 (04) 485-494
  • 39 Shelton D. Patterns of treatment services and costs for young offenders with mental disorders. J Child Adolesc Psychiatr Nurs 2005; 18 (03) 103-112
  • 40 Hockenberry S, Wachter A, Sladky A. Juvenile residential facility census, 2014: Selected Findings. Available at: https://ojjdp.ojp.gov/sites/g/files/xyckuh176/files/pubs/250123.pdf. Accessed 2014
  • 41 Brady KT, Verduin ML. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Subst Use Misuse 2005; 40 (13-14): 2021-2041
  • 42 Hesse M. Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 2009; 9 (01) 6
  • 43 Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 2008; 69 (04) 621-632
  • 44 Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav 2012; 37 (01) 11-24
  • 45 Upadhyaya HP. Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician. Prim Care Companion J Clin Psychiatry 2008; 10 (03) 211-221
  • 46 Kukreja S, Kalra G, Shah N, Shrivastava A. Polypharmacy in psychiatry: a review. Mens Sana Monogr 2013; 11 (01) 82-99
  • 47 Ito H, Koyama A, Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry 2005; 187 (03) 243-247
  • 48 Misawa F, Shimizu K, Fujii Y. et al. Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects? a cross-sectional study. BMC Psychiatry 2011; 11: 118
  • 49 Hulvershorn LA, Quinn PD, Scott EL. Treatment of adolescent substance use disorders and co-occurring internalizing disorders: a critical review and proposed model. Curr Drug Abuse Rev 2015; 8 (01) 41-49